Management of Primary Dysmenorrhea with Nexplanon

Medical Necessity Assessment

• The American Academy of Pediatrics supports the use of implants for adolescents with dysmenorrhea 2
• Nexplanon is considered medically necessary for management of primary dysmenorrhea in adolescents and adults 2
• Long-acting reversible contraceptives (LARCs) like Nexplanon are recommended as first-line options for adolescents due to their superior efficacy and low adherence requirements 1, 2

Clinical Evidence Supporting Use

• Nexplanon is highly effective with a failure rate of less than 1% and may remain in place for 3 years 2
• The implant is particularly suitable for adolescents who prefer a method that does not require regular adherence 1

Appropriateness for This Patient

• The patient is an 18-year-old female with documented primary dysmenorrhea 2
• Transitioning from Depo to Nexplanon is appropriate for long-term management of dysmenorrhea 2

Regulatory and Coverage Status

• Etonogestrel implants (Nexplanon) are FDA-approved for contraception and have established clinical use for management of primary dysmenorrhea 2
• The procedure is covered under the plan when medical necessity criteria are met for primary dysmenorrhea 2
• This is not considered experimental or investigational as it is an established treatment with substantial clinical evidence supporting its use 1, 2

Potential Benefits and Considerations

• For adolescents specifically, implants have been shown to have higher continuation rates compared to other contraceptive methods 1